Another name reporting 2Q earnings this week: $UNH 
#UnitedHealth announced a therapy called Level2 to support to Type 2 diabetes &amp; to help predict potential #COVID19 infections; also developed FDA-approved swab protocol to improve safety/efficiency while testing. @TDANetwork https://t.co/CqjpXxoNjy